JP2000501295A - 精製フィブリン単量体を基質に用いる血液凝固▲xiii▼因子の酵素活性測定方法 - Google Patents
精製フィブリン単量体を基質に用いる血液凝固▲xiii▼因子の酵素活性測定方法Info
- Publication number
- JP2000501295A JP2000501295A JP11504191A JP50419199A JP2000501295A JP 2000501295 A JP2000501295 A JP 2000501295A JP 11504191 A JP11504191 A JP 11504191A JP 50419199 A JP50419199 A JP 50419199A JP 2000501295 A JP2000501295 A JP 2000501295A
- Authority
- JP
- Japan
- Prior art keywords
- coagulation factor
- blood coagulation
- factor xiii
- fibrin
- fibrin monomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
- G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
- G01N2333/91085—Transglutaminases; Factor XIIIq (2.3.2.13)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ecology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.血液凝固XIII因子を含有しない精製フィブリン単量体を基質に使用して血液 凝固XIII因子により形成されたフィブリン架橋の程度を検知することによる血液 凝固XIII因子の酵素活性測定方法。 2.フィブリン単量体を、トロンビンと塩化カルシウムの存在下で、血液凝固XI II因子により反応させ、生成したフィブリン凝固物をSDS−ポリアクリルアミ ドゲル電気泳動により調べることを特徴とする、請求項1に記載の血液凝固XIII 因子の酵素活性測定方法。 3.フィブリン単量体を、トロンビンと塩化カルシウムの存在下で、血液凝固XI II因子と反応させた後、形成されたγ−γ二量体とγ単量体の量的比率によって 血液凝固XIII因子の酵素活性を決定することを特徴とする、請求項1に記載の血 液凝固XIII因子の酵素活性測定方法。 4.フィブリン単量体を、トロンビンと塩化カルシウムの存在下で、血液凝固XI II因子と反応させた後、吸光度を測定することによって、血液凝固XIII因子の酵 素活性を決定することを特徴とする、請求項1に記載の血液凝固XIII因子の酵素 活性測定方法。 5.フィブリン単量体でコーティングされたマイクロプレートを用いることによ って血液凝固XIII因子の酵素活性を決定することを特徴とする、請求項1に記載 の血液凝固XIII因子の酵素活性測定方法。 6.トロンビンで処理したフィブリノゲンから得られた非共有(non-Covalent )フィブリン重合体を適当な溶媒で洗浄することにより血液凝固XIII因子活性を 含まない精製フィブリン単量体を製造する方法。 7.血液凝固XIII因子を含まないフィブリン単量体を基質に使用することを特徴 とする転移グルタミナーゼの活性測定方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1997/25516 | 1997-06-18 | ||
KR1019970025516A KR100222292B1 (ko) | 1997-06-18 | 1997-06-18 | 피브린 단량체를 이용한 혈액 응고 제 13인자의활성 측정방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000501295A true JP2000501295A (ja) | 2000-02-08 |
JP3193728B2 JP3193728B2 (ja) | 2001-07-30 |
Family
ID=19510077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50419199A Expired - Fee Related JP3193728B2 (ja) | 1997-06-18 | 1998-06-16 | 精製フィブリン単量体を基質に用いる血液凝固▲xiii▼因子の酵素活性測定方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US6406874B1 (ja) |
EP (1) | EP0956363B1 (ja) |
JP (1) | JP3193728B2 (ja) |
KR (1) | KR100222292B1 (ja) |
AT (1) | ATE251221T1 (ja) |
DE (1) | DE69818639T2 (ja) |
WO (1) | WO1998058078A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10046187A1 (de) * | 2000-09-13 | 2002-03-21 | Univ Schiller Jena | Verfahren zur Messung der Aktivität von Gerinnungsfaktor XIIIa |
US20070125392A1 (en) * | 2005-12-01 | 2007-06-07 | Sdgi Holdings, Inc. | Systems and methods of accounting for surgical instruments and disposables |
CN113025685A (zh) * | 2021-03-25 | 2021-06-25 | 哈尔滨瀚邦医疗科技有限公司 | 一种测定凝血因子xiii活性的方法及其在猪血制品检测中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453359A (en) * | 1988-06-13 | 1995-09-26 | American Biogenetic Sciences, Inc. | Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
DE3834233A1 (de) | 1988-10-07 | 1990-04-19 | Max Planck Gesellschaft | Verfahren zur aktivitaetsbestimmung von transglutaminasen |
DE4038899C2 (de) | 1990-12-06 | 1995-01-19 | Dempfle Carl Erik Dr Med | Verfahren und Reagenzien zur Bestimmung der enzymatischen Aktivität von Transglutaminasen (EC 2.3.2.13) |
EP0577699A4 (en) * | 1991-03-11 | 1995-03-15 | Gen Hospital Corp | COMPOSITIONS AND METHODS INHIBITING ACTIVATION OF THE ACTIVE FACTOR XIII. |
JP3224607B2 (ja) * | 1992-09-11 | 2001-11-05 | 株式会社アズウェル | 血液凝固第xiii因子活性測定方法および該測定用試薬キット |
DE4402631A1 (de) * | 1994-01-29 | 1995-08-03 | Boehringer Mannheim Gmbh | Verfahren zur Bestimmung von Gerinnungsparametern |
US5464471A (en) * | 1994-11-10 | 1995-11-07 | Whalen Biomedical Inc. | Fibrin monomer based tissue adhesive |
-
1997
- 1997-06-18 KR KR1019970025516A patent/KR100222292B1/ko not_active IP Right Cessation
-
1998
- 1998-06-16 US US09/242,436 patent/US6406874B1/en not_active Expired - Fee Related
- 1998-06-16 AT AT98929875T patent/ATE251221T1/de active
- 1998-06-16 EP EP98929875A patent/EP0956363B1/en not_active Expired - Lifetime
- 1998-06-16 DE DE69818639T patent/DE69818639T2/de not_active Expired - Lifetime
- 1998-06-16 JP JP50419199A patent/JP3193728B2/ja not_active Expired - Fee Related
- 1998-06-16 WO PCT/KR1998/000160 patent/WO1998058078A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69818639T2 (de) | 2004-08-05 |
EP0956363B1 (en) | 2003-10-01 |
EP0956363A1 (en) | 1999-11-17 |
DE69818639D1 (de) | 2003-11-06 |
KR19990002006A (ko) | 1999-01-15 |
ATE251221T1 (de) | 2003-10-15 |
KR100222292B1 (ko) | 1999-10-01 |
WO1998058078A1 (en) | 1998-12-23 |
US6406874B1 (en) | 2002-06-18 |
JP3193728B2 (ja) | 2001-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4486999B2 (ja) | 凝固パラメーターを決定するためのキット | |
JP3224607B2 (ja) | 血液凝固第xiii因子活性測定方法および該測定用試薬キット | |
Carrell et al. | Hereditary dysfibrinogenemia in a patient with thrombotic disease | |
Fletcher et al. | The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally | |
Soria et al. | A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis | |
US20030064414A1 (en) | Rapid assessment of coagulation activity in whole blood | |
EP2235542B1 (en) | Diagnostic in vitro method for assessing von willebrand disease and increased bleeding risk associated with von willebrand disease and acquired or congenital disorders of platelet function | |
JPH06258326A (ja) | エンドトキシン特異的測定剤 | |
Ragni et al. | Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease | |
Verhovsek et al. | Laboratory testing for fibrinogen abnormalities | |
Weinstein et al. | Quantitative abnormality of an Aα chain molecular weight form in the fibrinogen of cirrhotic patients | |
Yan et al. | A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release | |
JP3193728B2 (ja) | 精製フィブリン単量体を基質に用いる血液凝固▲xiii▼因子の酵素活性測定方法 | |
Lefkowitz et al. | Fibrinogen Longmont: a dysfibrinogenemia that causes prolonged clot‐based test results only when using an optical detection method | |
JP5665264B2 (ja) | 安定なd−ダイマー液体製剤 | |
Amrani et al. | Separation and analysis of the major forms of plasma fibronectin | |
Lane et al. | Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release | |
Benz | Clotting factors and fibrinogen split products in the extravascular space | |
Lane et al. | An abnormal fibrinogen with delayed fibrinopeptide A release | |
Ball et al. | Fibrin formation and dissolution in women receiving oral contraceptive drugs | |
AU3133600A (en) | Test kit for analysing factor viii-splitting protease | |
JPH1090273A (ja) | 抗トロンビンiii含有溶液中のグリコサミノグリカンを定量する方法 | |
Exner et al. | Fibrinogen Adelaide: a familial hypodysfibrinogenaemia associated with abnormal alpha chains | |
JPS6257219B2 (ja) | ||
CN114252609A (zh) | 一种基质金属蛋白酶-9的检测试剂盒及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090525 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100525 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110525 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110525 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120525 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120525 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130525 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140525 Year of fee payment: 13 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |